Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus

被引：25

作者：

Cash B.D. ^{[1
]}

Johnston L.R. ^{[2
]}

Johnston M.H. ^{[2
]}

机构：

[1] Department of Gastroenterology, National Naval Medical Center, Bethesda, MD 20889, Wisconsin Avenue

[2] Lancaster Gastroenterology, Inc., Lancaster, PA 17604-3200

来源：

World Journal of Surgical Oncology | / 5卷 / 1期

关键词：

Esophageal Cancer; Lansoprazole; Esophageal Carcinoma; African American Male; Sustained Remission;

D O I：

10.1186/1477-7819-5-34

中图分类号：

学科分类号：

摘要：

Background: Esophageal carcinoma is the ninth most prevalent cancer worldwide with squamous cell carcinoma (SCCA) and adenocarcinoma accounting for the vast majority of new cases (13,900 in 2003). Cure rates in the U.S. are less than 10%, similar to lung cancer. More than 50% of patients with esophageal carcinoma present with unresectable or metastatic disease, are not surgical candidates, or display disease progression despite the addition of neoadjuvant chemoradiotherapy to surgery. Need for improved palliation exits. Case presentation: This case describes a 73-year-old African American male who presented with recurrent squamous cell carcinoma (SCCA) of the esophagus who has a achieved complete remission for 24 months via endoscopic cryospray ablation. Conclusion: Endoscopic cryo spray ablation warrants further investigation as a palliative treatment modality for esophageal cancer. This is the first reported case in the medical literature. © 2007 Cash et al; licensee BioMed Central Ltd.

引用

共 20 条

[1]

Sun W., Haller D., Oncology:VI Pancreatic, gastric and other gastrointestinal cancers, ACP Medicine, (2004)

[2]

Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J., Cancer statistics, 2003, CA Cancer J Clin, 53, pp. 5-26, (2003)

[3]

Koshy M., Esiashvilli N., Landry J.C., Thomas C.R., Matthews R.H., Multiple management modalities in esophageal cancer: Epidemiology, presentation and progression, work-up, and surgical approaches, Oncologist, 9, pp. 137-146, (2004)

[4]

Posner M.C., Forastiere A.A., Minsky B.D., Cancer of the Esophagus, Cancer: Principles & Practice of Oncology, (2005)

[5]

Koshy M., Esiashvilli N., Landry J.C., Thomas C.R., Matthews R.H., Multiple management modalities in esophageal cancer: Combined modality management approaches, Oncologist, 9, pp. 147-159, (2004)

[6]

Johnston M.H., Schoenfeld P.S., Mysore J., Kita J.A., Dubois A., Endoscopic cryotherapy: A new technique for tissue ablation in theesophagus, Am J Gastroenterol, 92, (1997)

[7]

Johnston M., Horwhat J., Dubois A., Schoenfeld P.S., Endoscopic cryotherapy in the swine esophagus: A follow-up study, Gastrointest Endosc, 49, (1999)

[8]

Johnston M.H., Schoenfeld P., Mysore J.V., Dubois A., Endoscopic spray cryotherapy: A new technique for mucosal ablation in the esophagus, Gastrointest Endosc, 50, pp. 86-92, (1999)

[9]

Johnston M.H., Horwhat J.D., Haluszka O., Moses F.M., Depth of injury following spray cryotherapy: EUS assisted evaluation of mucosal ablation and subsequent healing in the swine model, Gastrointest Endosc, 51, (2000)

[10]

Johnston M.H., Eastone J.A., Horwhat J.D., Reversal of barrett's esophagus with cryotherapy, Am J Gastroenterol, 98, SUPPL. A30, (2003)

← 1 2 →